Immediate Impact
69 standout
Citing Papers
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Works of Shun Ito being referenced
Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shun Ito | 37 | 82 | 182 | 134 | 37 | 331 | |
| María Isabel Del Olmo-García | 15 | 144 | 171 | 100 | 38 | 371 | |
| Noritsugu Ohashi | 76 | 169 | 156 | 131 | 24 | 338 | |
| Hideki Ohgo | 42 | 88 | 50 | 136 | 37 | 349 | |
| Guobo Xie | 21 | 58 | 185 | 160 | 23 | 323 | |
| D Sinagra | 19 | 30 | 128 | 126 | 24 | 311 | |
| S Kuroki | 94 | 82 | 67 | 101 | 41 | 339 | |
| Francesco Virdis | 26 | 152 | 57 | 122 | 26 | 330 | |
| Hyun Il Seo | 67 | 112 | 76 | 129 | 30 | 282 | |
| Yuxiu Liu | 37 | 108 | 52 | 129 | 33 | 253 | |
| Jacqueline Córdova‐Gallardo | 30 | 42 | 72 | 242 | 28 | 338 |
All Works
Login with ORCID to disown or claim papers
Loading papers...